<DOC>
	<DOCNO>NCT01003288</DOCNO>
	<brief_summary>Haukeland University Hospital approximately 8000 employee many front line receive pandemic A/H1N1 vaccine . We propose conduct safety immunogenicity study subject</brief_summary>
	<brief_title>Studies Pandemic Influenza ( H1N1 ) 2009 Vaccine Bergen</brief_title>
	<detailed_description>The investigator conduct safety immunogenicity study health employee detail : - Examine adverse event employee vaccination use adverse event form - Examine immunogenicity vaccine collect blood sample day 0 , 21 &amp; 42 vaccination ( 500 people ) - Provide detailed time course immune response vaccination novel influenza H1N1 virus include kinetics T-cell , B-cell antibody responses 50 volunteer - Investigate long last immunity induce vaccine - Examine ability vaccine induce cross-reactive immunity H1N1 strain .</detailed_description>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Signed informed consent Subjects able understand comply study protocol complete Adverse Event Form Subjects able attend schedule visit kinetic study Persons history anaphylaxis serious reaction vaccine Person known hypersensitivity vaccine component Persons temperature &gt; 38oC previous 72 hour Persons acute respiratory infection last 7 day Suspected noncompliance</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>H1N1 pandemic vaccine immunogenicity safety</keyword>
	<keyword>Health employee</keyword>
</DOC>